Cargando…
Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders
Celiac Disease (CD) is an immune-mediated and gluten-related disorder whose prevalence is higher in children affected with other autoimmune disorders, including diabetes mellitus type 1, autoimmune thyroiditis, and others. As regards Juvenile Idiopathic Arthritis (JIA) and other pediatric rheumatic...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878661/ https://www.ncbi.nlm.nih.gov/pubmed/35207358 http://dx.doi.org/10.3390/jcm11041089 |
_version_ | 1784658712483332096 |
---|---|
author | Poddighe, Dimitri Romano, Micol Dossybayeva, Kuanysh Abdukhakimova, Diyora Galiyeva, Dinara Demirkaya, Erkan |
author_facet | Poddighe, Dimitri Romano, Micol Dossybayeva, Kuanysh Abdukhakimova, Diyora Galiyeva, Dinara Demirkaya, Erkan |
author_sort | Poddighe, Dimitri |
collection | PubMed |
description | Celiac Disease (CD) is an immune-mediated and gluten-related disorder whose prevalence is higher in children affected with other autoimmune disorders, including diabetes mellitus type 1, autoimmune thyroiditis, and others. As regards Juvenile Idiopathic Arthritis (JIA) and other pediatric rheumatic disorders, there is no clear recommendation for CD serological screening. In this review, we analyze all the available clinical studies investigating CD among children with JIA (and other rheumatic diseases), in order to provide objective data to better understand the necessity of CD serological screening during the follow-up. Based on the present literature review and analysis, >2.5% patients with JIA were diagnosed with CD; however, the CD prevalence in JIA patients may be even higher (>3–3.5%) due to several study limitations that could have underestimated CD diagnosis to a variable extent. Therefore, serological screening for CD in children affected with JIA could be recommended due to the increased CD prevalence in these patients (compared to the general pediatric population), and because these JIA patients diagnosed with CD were mostly asymptomatic. However, further research is needed to establish a cost-effective approach in terms of CD screening frequency and modalities during the follow-up for JIA patients. Conversely, at the moment, there is no evidence supporting a periodical CD screening in children affected with other rheumatic diseases (including pediatric systemic lupus erythematosus, juvenile dermatomyositis, and systemic sclerosis). |
format | Online Article Text |
id | pubmed-8878661 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88786612022-02-26 Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders Poddighe, Dimitri Romano, Micol Dossybayeva, Kuanysh Abdukhakimova, Diyora Galiyeva, Dinara Demirkaya, Erkan J Clin Med Review Celiac Disease (CD) is an immune-mediated and gluten-related disorder whose prevalence is higher in children affected with other autoimmune disorders, including diabetes mellitus type 1, autoimmune thyroiditis, and others. As regards Juvenile Idiopathic Arthritis (JIA) and other pediatric rheumatic disorders, there is no clear recommendation for CD serological screening. In this review, we analyze all the available clinical studies investigating CD among children with JIA (and other rheumatic diseases), in order to provide objective data to better understand the necessity of CD serological screening during the follow-up. Based on the present literature review and analysis, >2.5% patients with JIA were diagnosed with CD; however, the CD prevalence in JIA patients may be even higher (>3–3.5%) due to several study limitations that could have underestimated CD diagnosis to a variable extent. Therefore, serological screening for CD in children affected with JIA could be recommended due to the increased CD prevalence in these patients (compared to the general pediatric population), and because these JIA patients diagnosed with CD were mostly asymptomatic. However, further research is needed to establish a cost-effective approach in terms of CD screening frequency and modalities during the follow-up for JIA patients. Conversely, at the moment, there is no evidence supporting a periodical CD screening in children affected with other rheumatic diseases (including pediatric systemic lupus erythematosus, juvenile dermatomyositis, and systemic sclerosis). MDPI 2022-02-18 /pmc/articles/PMC8878661/ /pubmed/35207358 http://dx.doi.org/10.3390/jcm11041089 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Poddighe, Dimitri Romano, Micol Dossybayeva, Kuanysh Abdukhakimova, Diyora Galiyeva, Dinara Demirkaya, Erkan Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders |
title | Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders |
title_full | Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders |
title_fullStr | Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders |
title_full_unstemmed | Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders |
title_short | Celiac Disease in Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Disorders |
title_sort | celiac disease in juvenile idiopathic arthritis and other pediatric rheumatic disorders |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8878661/ https://www.ncbi.nlm.nih.gov/pubmed/35207358 http://dx.doi.org/10.3390/jcm11041089 |
work_keys_str_mv | AT poddighedimitri celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders AT romanomicol celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders AT dossybayevakuanysh celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders AT abdukhakimovadiyora celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders AT galiyevadinara celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders AT demirkayaerkan celiacdiseaseinjuvenileidiopathicarthritisandotherpediatricrheumaticdisorders |